Arrhythmia Alliance News & Events
Don't let cancelled/postponed conferences stop your educational learning! We have a large number of educational presentations available online HERE
PATIENT DIES AFTER BEING DENIED ACCESS TO LIFE-SAVING TREATMENT DUE TO LACK OF NHS FUNDING
Arrhythmia Alliance is calling on NHS England to reconsider its ‘Commissioning through Evaluation’ (CtE) process, following the death of a high risk atrial fibrillation (AF) patient from a bleed to the brain after being refused a potentially life-saving treatment. The evaluation process of left atrial appendage occlusion (LAAO), a treatment approved by the FDA and used across Europe, has meant hundreds of patients being denied access to this treatment with no guarantee when the evaluation will be completed to allow access.
ARRHYTHMIA ALLIANCE WELCOMES NHS CALL TO PROVIDE TESTS TO IDENTIFY PEOPLE WITH UNDIAGNOSED HEART RHYTHM DISORDERS
Local health authorities do not mandate or commission manual pulse rhythm checks recommended as part of NHS health check service
LOCAL HEART RHYTHM CHARITY PARTNERS WITH FBI
Wednesday 2 August: Chipping Norton, UK: Today at the annual FBI National Academy Associates conference held in Washington DC, USA, Trudie Lobban MBE, Founder and Trustee, Arrhythmia Alliance is calling on all delegates in attendance and to Police Chiefs across the United States to place an automated external defibrillator (AED) in every police vehicle to help save lives from sudden cardiac death – the number one killer in the USA.
High Risk Patients Denied Access to Life-saving Treatment
Arrhythmia Alliance is concerned about high risk arrhythmia (heart rhythm disorder) patients who are being secretly denied access to life-saving treatment due to an 'indefinite' NHS England 'evaluation process'.
Interview with Trudie Lobban MBE, Founder & Trustee of Arrhythmia Alliance
Arrhythmia Alliance is a coalition of charities, patient groups, patients, carers, healthcare professionals, policy-makers, politicians, allied professionals and all those involved in the care of or affected by cardiac arrhythmias. Arrhythmia Alliance works in collaboration to improve diagnosis, treatment and quality of life for all those suffering with arrhythmias.
Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE)
Atrial fibrillation (AF) is the most common cardiac arrhythmia, occurring in 1–2% of the general population. Its prevalence varies between continents and ethnicity, but the estimated number of patients with AF worldwide might be between 30 and 100 million.1 This prevalence is expected to increase significantly in the next 30–50 years due to an ageing population, and increasing risk factors to develop AF, including arterial hypertension and diabetes.2–5 In all populations studied, both prevalence and incidence are higher in men than in women and increase with age.6
Happitech, Arrhythmia Alliance and Bug Labs launch Heart for Heart e-health initiative
Happitech, Arrhythmia Alliance and Bug Labs will announce the launch of the Heart for Heart e-health initiative. This initiative invites people to participate in the world’s largest crowdsourced heart health initiative by inviting them to contribute their heart rhythm data using the free Heart for Heart iPhone App.
Heart For Heart
Happitech, Arrhythmia Alliance and Bug Labs will announce the launch of the Heart for Heart campaign during World Heart Rhythm Week. This campaign invites people to participate in the world’s largest crowdsourced heart health initiative by recruiting them to contribute their heart rhythm data using the free Heart for Heart iPhone App.
Week to Honour James Bond
Arrhythmia Alliance honours Sir Roger Moore during World Heart Rhythm Week.